MobileX Announced as the Exclusive Wireless Carrier Partner of X Games Aspen 2024
IRVINE, Calif., Jan. 22, 2024 /PRNewswire/ — MobileX, the most customizable wireless service designed to save consumers money, today announced…
Venteur Partners with TRUE Network to Bring Personalized Health Insurance Options to Employers Nationwide
BERKELEY, Calif., Jan. 22, 2024 /PRNewswire/ — Venteur, the digital health startup helping companies provide personalized health insurance options to…
Bishop-Wisecarver Welcomes New Southeastern Regional Sales Manager
PITTSBURG, Calif., Jan. 22, 2024 /PRNewswire/ — Bishop-Wisecarver, a leading manufacturer of proven guided motion solutions that excel in harsh…
Adient announces preliminary Q1 fiscal 2024 results
Adient to announce Q1FY24 financial results on Feb. 7, 2024 PLYMOUTH, Mich., Jan. 22, 2024 /PRNewswire/ — Adient…
FULL SWING TO DEBUT NEW TECHNOLOGY AT 2024 PGA SHOW
The most innovative brand in golf is going to preview their latest upgrades CARLSBAD, Calif. and ORLANDO, Fla., Jan. 22,…
CCV CAPITAL: Strategies for Chinese Enterprises to Breakthrough in the New Situation
BEIJING, Jan. 22, 2024 /PRNewswire/ — In the era of Globalization 2.0, amid various challenges, how can Chinese enterprises break…
Appotronics appears on CES 2024 to showcase the automotive optics to the world stage
SHENZHEN, China, Jan. 22, 2024 /PRNewswire/ — CES 2024, the most influential technology meeting on the world, was held from…
Puck empowers Lebanon’s female entrepreneurs with launch of ‘Selfless Shelves’ initiative
BEIRUT, Jan. 22, 2024 /PRNewswire/ — Puck, a global brand with purpose, belonging to Arla Foods multinational dairy company, announced today…
MDRX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action – MDRX
NEW YORK, Jan. 21, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common…
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
SHANGHAI, Jan. 21, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the…
↑